Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
CoreCard benefited from its repriced and lengthened contract with Goldman, discussed in our 3Q24 letter. This amended contract...
— Avram Fisher
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on CoreCard Corp.
No other institutional pitches found for this ticker yet.
More institutional theses from Long Cast Advisers
With that in mind, and with earnings season in gear, Zimmer’s CEO recently shared positive commentary about the upcoming launch of its new robotic TKA platform on which PDEX, our largest holding, will be a major supplier: We recently announced a multi-year limited distribution and supply agreement with THINK Surgical to distribute an exclusive version of the only wireless handheld TMINI Miniature Robotic System compatible with Persona Knee. Most excitingly, we...
RSSS, which has declined nearly 40% year to date, is no longer at top-five holding but remains a large position nonetheless. It is also...
MTRX remains a top five holding despite the stock declining 30% in the quarter. I had expected...